Noevir Holdings Co., Ltd. (TYO:4928)

Market Cap	140.04B
Revenue (ttm)	64.01B
Net Income (ttm)	7.94B
Shares Out	34.16M
EPS (ttm)	232.37
PE Ratio	17.64
Forward PE	17.50
Dividend	225.00 (5.49%)
Ex-Dividend Date	Sep 27, 2024

Volume	43,500
Average Volume	68,155
Open	4,105.00
Previous Close	4,100.00
Day's Range	4,095.00 - 4,145.00
52-Week Range	3,885.00 - 5,890.00
Beta	0.03
RSI	47.44
Earnings Date	May 8, 2025

About Noevir Holdings

Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company’s Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and se...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1964
• Employees: 1,369
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4928

Financial Performance

In 2024, Noevir Holdings's revenue was 63.82 billion, an increase of 2.03% compared to the previous year's 62.55 billion. Earnings were 7.97 billion, an increase of 3.87%.